Show simple item record

dc.contributor.authorSchramm, Birgit*
dc.contributor.authorValeh, Parastou*
dc.contributor.authorBaudin, Elisabeth*
dc.contributor.authorMazinda, Charles S*
dc.contributor.authorSmith, Richard*
dc.contributor.authorPinoges, Loretxu*
dc.contributor.authorSundaygar, Timothy*
dc.contributor.authorZolia, Yah M*
dc.contributor.authorJones, Joel J*
dc.contributor.authorComte, Eric*
dc.contributor.authorBruneel, Arnaud*
dc.contributor.authorBranger, Michel*
dc.contributor.authorJullien, Vincent*
dc.contributor.authorCarn, Gwenaelle*
dc.contributor.authorKiechel, Jean-René*
dc.contributor.authorAshley, Elizabeth A*
dc.contributor.authorGuérin, Philippe J*
dc.date.accessioned2014-01-20T21:32:37Z
dc.date.available2014-01-20T21:32:37Z
dc.date.issued2013-07-17
dc.identifier.citationTolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. 2013, 12 (1):250 Malar. J.en_GB
dc.identifier.issn1475-2875
dc.identifier.pmid23866736
dc.identifier.doi10.1186/1475-2875-12-250
dc.identifier.urihttp://hdl.handle.net/10144/311613
dc.description.abstractSafety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.
dc.languageENG
dc.language.isoenen
dc.publisherBioMed Centralen_GB
dc.rightsPublished by BioMed Central, [url]http://www.malariajournal.com/[/url] Archived on this site by Open Access permissionen_GB
dc.subjectMalariaen_GB
dc.subjectPediatricsen_GB
dc.titleTolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberiaen
dc.identifier.journalMalaria Journalen_GB
refterms.dateFOA2019-03-04T10:58:40Z
html.description.abstractSafety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.


Files in this item

Thumbnail
Name:
Schramm et al-2013-Tolerability ...
Size:
365.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record